Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-22

Clinical Trial Update: Renal Protective Effects of Restricted Protein Dietary With α-keto Acid in CAPD Patients [NA]

View source ↗

Summary

A completed clinical trial evaluated the renal-protective effects of a restricted protein diet with α-keto acids in CAPD patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Restricted protein diet with α-keto acids (Alpha-keto acids dietary supplement)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Renal Function Disorder | NA | Status: COMPLETED